Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Corey Hayes to Analgesics, Opioid

This is a "connection" page, showing publications Corey Hayes has written about Analgesics, Opioid.

 
Connection Strength
  
 
 
5.559
  
  1. Mahashabde RV, Shrikhande MA, Han X, Martin BC, ElHassan NO, Hayes CJ. Concordance of opioid exposure in all-payer claims databases with prescription drug monitoring program database using Arkansas as a case example. Health Serv Res. 2023 08; 58(4):938-947.
    View in: PubMed
    Score: 0.588
  2. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study. J Pain. 2021 12; 22(12):1709-1721.
    View in: PubMed
    Score: 0.530
  3. Hayes CJ, Morgan HR, Cucciare MA, George M, Goree JH, Hudson TJ, Ray-Griffith SL, Tobey L, Bollinger M, Winston K, Praseuth A, Smith GR. A program evaluation of Arkansas Improving Multidisciplinary Pain Care and Treatment (AR-IMPACT). J Opioid Manag. 2021 May-Jun; 17(3):227-239.
    View in: PubMed
    Score: 0.524
  4. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction. 2020 06; 115(6):1098-1112.
    View in: PubMed
    Score: 0.479
  5. Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Qual Life Res. 2018 Nov; 27(11):3021-3035.
    View in: PubMed
    Score: 0.433
  6. Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health-Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health Serv Res. 2018 10; 53(5):3329-3349.
    View in: PubMed
    Score: 0.421
  7. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. J Opioid Manag. 2017 Mar/Apr; 13(2):95-103.
    View in: PubMed
    Score: 0.393
  8. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiol Drug Saf. 2015 Nov; 24(11):1180-8.
    View in: PubMed
    Score: 0.352
  9. Hayes CJ, Martin BC, Hoggatt KJ, Cucciare MA, Hudson TJ, Gordon AJ. Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. Subst Use Addctn J. 2024 Oct; 45(4):727-735.
    View in: PubMed
    Score: 0.164
  10. Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiol Drug Saf. 2022 10; 31(10):1075-1090.
    View in: PubMed
    Score: 0.142
  11. Hayes CJ, Goree J, Turpin J, Ortiz H, Smith GR, Gokarakonda SB, Hyde C, Cucciare MA. Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas. J Prev (2022). 2022 06; 43(3):337-357.
    View in: PubMed
    Score: 0.138
  12. Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Subst Abus. 2022; 43(1):956-963.
    View in: PubMed
    Score: 0.137
  13. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug Alcohol Depend. 2022 02 01; 231:109236.
    View in: PubMed
    Score: 0.137
  14. Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction. 2022 04; 117(4):946-968.
    View in: PubMed
    Score: 0.136
  15. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on pain intensity: a retrospective cohort study. Pain. 2020 05; 161(5):979-988.
    View in: PubMed
    Score: 0.122
  16. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.
    View in: PubMed
    Score: 0.120
  17. Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiol Drug Saf. 2019 08; 28(8):1117-1124.
    View in: PubMed
    Score: 0.115
  18. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med. 2019 08; 34(8):1419-1426.
    View in: PubMed
    Score: 0.112
  19. Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. J Pain. 2017 11; 18(11):1374-1383.
    View in: PubMed
    Score: 0.101
  20. Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 Mar 17; 66(10):265-269.
    View in: PubMed
    Score: 0.099
  21. Martin BC, Hayes C, Austen M, Hudson T. Author response to "Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion". Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):477-8.
    View in: PubMed
    Score: 0.092
  22. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186.
    View in: PubMed
    Score: 0.040
  23. Wang L, Hong PJ, Jiang W, Rehman Y, Hong BY, Couban RJ, Wang C, Hayes CJ, Juurlink DN, Busse JW. Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies. CMAJ. 2023 10 23; 195(41):E1399-E1411.
    View in: PubMed
    Score: 0.039
  24. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 03 01; 39(3):107-118.
    View in: PubMed
    Score: 0.037
  25. Smith AM, Acharya M, Hudson T, Hayes C, Porter A, Turpin J, Bona J, Utecht J, Martin BC. Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):648-654.e3.
    View in: PubMed
    Score: 0.037
  26. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957.
    View in: PubMed
    Score: 0.036
  27. Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. Am J Public Health. 2022 02; 112(S1):S66-S76.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.